LSV Asset Management reduced its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 0.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,258,815 shares of the real estate investment trust's stock after selling 22,700 shares during the quarter. LSV Asset Management owned 1.79% of Sabra Healthcare REIT worth $74,401,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. UMB Bank n.a. increased its stake in Sabra Healthcare REIT by 379.6% during the 1st quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock worth $36,000 after purchasing an additional 1,621 shares in the last quarter. Assetmark Inc. boosted its holdings in shares of Sabra Healthcare REIT by 37.8% in the first quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust's stock valued at $63,000 after buying an additional 989 shares during the period. Fifth Third Bancorp increased its position in shares of Sabra Healthcare REIT by 110.3% during the first quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust's stock worth $67,000 after acquiring an additional 2,011 shares in the last quarter. GF Fund Management CO. LTD. acquired a new stake in shares of Sabra Healthcare REIT during the fourth quarter worth $74,000. Finally, Harbor Capital Advisors Inc. raised its holdings in shares of Sabra Healthcare REIT by 17.2% during the first quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust's stock worth $76,000 after acquiring an additional 642 shares during the period. Institutional investors and hedge funds own 99.40% of the company's stock.
Insider Activity at Sabra Healthcare REIT
In other news, Director Michael J. Foster sold 11,000 shares of the stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total transaction of $200,420.00. Following the completion of the transaction, the director directly owned 64,725 shares in the company, valued at $1,179,289.50. This represents a 14.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.20% of the stock is currently owned by corporate insiders.
Sabra Healthcare REIT Price Performance
Shares of SBRA opened at $18.29 on Friday. The stock has a market capitalization of $4.35 billion, a P/E ratio of 31.00, a P/E/G ratio of 1.52 and a beta of 0.86. Sabra Healthcare REIT, Inc. has a twelve month low of $15.60 and a twelve month high of $20.03. The company has a 50 day moving average of $18.14 and a 200-day moving average of $17.50. The company has a quick ratio of 4.22, a current ratio of 4.22 and a debt-to-equity ratio of 0.89.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.01. Sabra Healthcare REIT had a net margin of 19.55% and a return on equity of 5.14%. The company had revenue of $183.54 million during the quarter, compared to analysts' expectations of $180.23 million. During the same period last year, the business earned $0.35 EPS. The business's quarterly revenue was up 10.1% on a year-over-year basis. As a group, equities research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.
Sabra Healthcare REIT Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 30th. Stockholders of record on Friday, May 16th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.6%. The ex-dividend date was Friday, May 16th. Sabra Healthcare REIT's dividend payout ratio is currently 203.39%.
Wall Street Analysts Forecast Growth
Separately, Scotiabank increased their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a report on Monday, June 23rd. Three equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Sabra Healthcare REIT currently has an average rating of "Moderate Buy" and a consensus target price of $19.67.
Check Out Our Latest Stock Analysis on SBRA
Sabra Healthcare REIT Company Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Featured Articles
Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.